Co-Diagnostics, Inc. (CODX)

Co-Diagnostics Stock Forecast

CODX's stock price has decreased by -77.48% in the past year and price targets may not have had time to catch up.

Stock Price Forecast

The 2 analysts that cover Co-Diagnostics stock have a consensus rating of "Buy" and an average price target of $5.5, which forecasts a 1885.56% increase in the stock price over the next year. The lowest target is $1 and the highest is $10.

Price Target: $5.5 (+1885.56%)

Analyst Consensus: Buy

Target	Low	Average	Median	High
Price	$1.00	$5.50	$10	$10
Change	+261.01%	+1885.6%	+3510.1%	+3510.1%

* Price targets were last updated on Apr 28, 2025.

Analyst Ratings

The average analyst rating for Co-Diagnostics stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating	Feb '25	Mar '25	Apr '25	May '25	Jun '25	Jul '25
Strong Buy	0	0	1	1	1	1
Buy	0	0	0	0	0	0
Hold	1	1	1	1	1	1
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	1	1	2	2	2	2

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Jason Kolbert D. Boral Capital	D. Boral Capital	Strong Buy Initiates $10	Strong Buy	Initiates	$10	+3,510.11%	Apr 28, 2025
Yi Chen HC Wainwright & Co.	HC Wainwright & Co.	Hold Maintains $1.5 → $1	Hold	Maintains	$1.5 → $1	+261.01%	Mar 28, 2025
Yi Chen HC Wainwright & Co.	HC Wainwright & Co.	Hold Reiterates $1.5	Hold	Reiterates	$1.5	+441.52%	Nov 11, 2024
Yi Chen HC Wainwright & Co.	HC Wainwright & Co.	Hold Maintains $2 → $1.5	Hold	Maintains	$2 → $1.5	+441.52%	Aug 12, 2024
Yi Chen HC Wainwright & Co.	HC Wainwright & Co.	Hold Reiterates $2	Hold	Reiterates	$2	+622.02%	Jun 17, 2024

More Analyst Ratings

Financial Forecast

Revenue This Year

484.50K

Decreased by -87.63%

from 3.92M

Revenue Next Year

688.50K

Increased by 42.11%

from 484.50K

EPS This Year

-1.09

from -1.24

EPS Next Year

-0.43

from -1.09

Fiscal Year	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Dec 31, 2020	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026	Dec 31, 2027
Revenue	74.55M	97.89M	34.22M	6.81M	3.92M	484.50K	688.50K	39.78M
Revenue Growth	34,579.90%	31.30%	-65.04%	-80.09%	-42.53%	-87.63%	42.11%	5,677.78%
EPS	1.52	1.23	-0.45	-1.20	-1.24	-1.09	-0.43	-0.33
EPS Growth	-	-19.08%	-	-	-	-	-	-
Forward PE	-	-	-	-	-	-	-	-
No. Analysts	-	-	-	-	-	4	4	3

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2025	2026	2027	2028	2029
High	997,500	1.4M	41.0M
Avg	484,500	688,500	39.8M
Low	n/a	n/a	38.2M

Revenue Growth

Revenue Growth	2025	2026	2027	2028	2029
High	-74.5%	192.7%	5,847.7%
Avg	-87.6%	42.1%	5,677.8%
Low	-	-	5,451.2%

EPS Forecast

EPS	2025	2026	2027
High	-0.71	-0.36	-0.34
Avg	-1.09	-0.43	-0.33
Low	-1.43	-0.49	-0.31

EPS Growth

EPS Growth	2025	2026	2027
High	-	-	-
Avg	-	-	-
Low	-	-	-

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.